Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review


April 16, 2013
28 Pages - SKU: GBDT5024249
License type:


Summary

Zhejiang Huahai Pharmaceutical Co., Ltd. (Huahai Pharmaceuticals) is a pharmaceutical company that conducts production and sale of formulations, Active Pharmaceutical Ingredients (API) and pharmaceutical intermediates. The company also offers technology services. The company's pharmaceutical preparation products include irbesartan tablets, didanosine dispersible buffered tablet and nevirapine capsules among others. Its products focus on the treatment of high blood pressure, depression and psychonosis. The company also distributes its products to international markets. Huahai Pharmaceuticals is the first pharmaceutical company in China to receive approval from the USFDA. Huahai Pharmaceuticals is headquartered in Zhejiang, China.

This comprehensive SWOT profile of Zhejiang Huahai Pharmaceutical Co., Ltd. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Additional Information


Report Excerpt

Section 6 – Appendix

The data and analysis within this report is driven by GlobalData. GlobalData gives you key information to drive sales, investment and deal making activity in your business. Our coverage includes 200,000 + reports on 185,000+ companies (including 150,000+ private) across 200+ countries and 29 industries. The key industries include Alternative Energy, Oil & Gas, Clean Technology, Technology and Telecommunication, Pharmaceutical and Healthcare, Power, Financial Services, Chemical and Metal & Mining.

More Pharmaceuticals Company reports by GlobalData

ZEUS Scientific, Inc. - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryZEUS Scientific, Inc. ( ZEUS) is a pharmaceuticals company. The company develops and manufactures clinical diagnostic tests for the in-vitro diagnostic markets. Its products include ...
Mystic Pharmaceuticals, Inc. - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryMystic Pharmaceuticals, Inc. (Mystic) is a pharmaceutical service company. The company develops and commercializes drug delivery systems. It offers services such as device manufacturing, drug ...
Hadasit Medical Research Services & Development Ltd - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryHadasit Medical Research Services & Development Ltd (Hadasit Ltd) is a biomedical technology company. It provides, promotes and commercializeS pre-clinical and clinical research and development ...
Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryDelcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted ...
See all reports like this >>